Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Laxmi V, Baxi"'
Autor:
Werner M Neuhausser, Laxmi V Baxi
Publikováno v:
F1000Research, Vol 2 (2013)
We present here a case of vasa previa in a multipara, diagnosed at the time of her late second trimester ultrasonogram. The patient subsequently underwent an elective cesarean section after 37 weeks gestation, giving birth to a healthy child with an
Externí odkaz:
https://doaj.org/article/8a3866ae994a44639518f11c01d85afe
Autor:
William Quish, Mitchell S. Cairo, Carmella van de Ven, Jessica Hochberg, Janet Ayello, Allyson Flower, Laxmi V. Baxi, Yaya Chu
Publikováno v:
Experimental Hematology. 46:38-47
Natural killer (NK) cells play a significant role in reducing relapse in patients with hematological malignancies after allogeneic stem cell transplantation, but NK cell number and naturally occurring inhibitory signals limit their capability. Interl
Autor:
Margaret Dziadosz, Laxmi V. Baxi
Publikováno v:
Blood Coagulation & Fibrinolysis. 27:481-489
Distribution of hereditary thrombophilic gene mutations differs globally. Prothrombin gene mutation G20210A is a common prothrombotic single-nucleotide polymorphism. In this systematic review, we provide a comprehensive report of the prevalence of pr
Autor:
Laxmi V. Baxi
Publikováno v:
Obstetrics & Gynecology. 136:634-634
Autor:
Laxmi V. Baxi, Lynn L. Simpson, Mitchell S. Cairo, Carmella van de Ven, Janet Ayello, Dustin Cairo, Prakash Satwani
Publikováno v:
Cytotherapy. 13:730-738
Interleukin (IL)-15 and fms-like tyrosine kinase-3 (FLT-3) are crucial factors for the development of human and murine natural killer (NK) cells. Previously, we have demonstrated significant ex vivo expansion and activation of unrelated cord blood (U
Autor:
L. Mobili, Druck Reinhardt Druck Basel, Ji Young Huh, David Pauzner, Keiji Tatsumi, Yoshiki Mikami, Harold Stanislaw, Munekazu Komada, Myung Seo Kang, C. Giorlandino, A. Zaccara, Joseph B. Lessing, Ignacio Herraiz, C. Brizzi, Irene T.M. Lindenburg, Jin Hee Kang, Gerard G. Nahum, Juan Balasch, Rohan Lourie, Frans J.C.M. Klumper, Hiroshi Fujiwara, Ishai Levin, Alberto Galindo, Surabhi Nanda, Debra J. Wolgemuth, Glenn Gardener, Geoff Daniels, M. De Gennaro, A. Nahom, Dick Oepkes, Sang Hee Jung, Yukiko Izumi, Ikuo Konishi, Won Bo Hahn, Ramesh Kuppusamy, Danielle Sodre, Katsura Minegishi, Avital Skornick Rapaport, Sung Woon Chang, Stephen Cattanach, Kazuyo Kakui, Inge L. van Kamp, Dong Hyun Cha, David Lora, Kypros H. Nicolaides, Ranjit Akolekar, Satz Mengensatzproduktion, A. Marciano, Yukiyasu Sato, Frank P.H.A. Vandenbussche, Laxmi V. Baxi, Joseph T. Thomas, Vladimir Buchman, Xiangyuan Wang, Shigehito Yamada, Kirstin Finning, Juan Carlos Melchor, D. Escribano, Ronni Gamzu, Scott Petersen, Park Hea Ree, M. Hoopmann, Benny Almog, E. Carnevale, Adriana Olog, K.O. Kagan, Ron Wolterbeek, Eirini Vaikousi, Eduard Gratacós, Javier de la Cruz
Publikováno v:
Fetal Diagnosis and Therapy. 29:I-IV
To predict the sex of newborns using first trimester fetal heart rate (FHR).This was a retrospective review of medical records and ultrasounds performed between 8 and 13 weeks of gestation. Continuous variables were compared using Student's t-tests w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e00677abcb72cfc465f129bb79602bf1
https://europepmc.org/articles/PMC4679415/
https://europepmc.org/articles/PMC4679415/
Publikováno v:
The Journal of reproductive medicine. 59(11-12)
Coexistence of complete mole and a live fetus is uncommon (1:22,000-100,000), more so with euploidy.We present a case of a molar pregnancy with a euploid fetus who had close fetal evaluation for second trimester bleeding. The patient presented at 29
Autor:
Prakash Satwani, C. Wade-Harris, Joanne Kurtzberg, Weiwei Fortino, Diana Pickering, Lynn L. Simpson, Laxmi V. Baxi, Carmella van de Ven, Janet Ayello, Mitchell S. Cairo, Warren G. Sanger
Publikováno v:
Biology of Blood and Marrow Transplantation. 12(6):608-622
Cord blood (CB) natural killer (NK) and lymphokine-activated killer (LAK) cytotoxic cells are poorly characterized but might be used to treat minimal residual and/or recurrent malignant disease. Currently, there is no mechanism to use CB for adoptive
Autor:
Janet Ayello, Mitchell S. Cairo, Lynn L. Simpson, Carmella van de Ven, Laxmi V. Baxi, Allison F. O'Neill, Prakash Satwani
Publikováno v:
British Journal of Haematology. 130:284-292
We have previously demonstrated dysregulation of IL-12 and IL-15 gene and protein expression between activated cord blood (CB) versus peripheral blood (PB) mononuclear cells (MNCs). In the present study, we compared IL-18 gene expression and protein